Seeking Alpha

United Therapeutics (UTHR) falls sharply after disclosing its late-stage drug for pulmonary...

United Therapeutics (UTHR) falls sharply after disclosing its late-stage drug for pulmonary arterial hypertension failed to improving walking distance for patients. The firm says it will still move forward to seek FDA approval based on an earlier positive study. Shares down 21% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|